scholarly journals Intellectual decline in patients with schizophrenia with comorbid type ii diabetes mellitus and alcoholism

2022 ◽  
pp. 26-34
Author(s):  
G. Р. Kostyuk ◽  
D. I. Cherepakhin ◽  
P. V. Aronov ◽  
G. N. Belskaya ◽  
I. A. Nikiforov

Comorbid conditions in general psychopathological practice need equally research in the field of psychiatry and narcology, as well as the development of issues of social practice in relation to mental patients. There is an opinion that comorbid mental pathologies are even more common than “pure” forms of diseases. In most cases of comorbid conditions, the medical community increasingly encounters clinical situations where “classic” symptoms and syndromes are deformed, mutually intertwined and, superimposed on the actual social situation of the patient, acquire an “unreal fancy character”.Schizophrenia remains one of the most urgent problems at the stage of modern psychiatry formation. Up to date there are 1.1% of men and 1.9% of women in the general population of patients. Schizophrenic spectrum disorders are often combined with a number of chronic pathologies that increase the negative impact on the neuro-cognitive sphere of a person. One of the main problems of modern urbanized society is type II diabetes and alcoholism. By increasing the negative impact on a person’s cognitive abilities, they accelerate the process of disintegration of personality and its social functioning. The intellectual level of patients with those chronic diseases that require patients to actively and consciously participate in the treatment process and social functioning can significantly affect the patient’s ability to learn, independently manage the disease, establish a high level of compliance and, as a result, the effectiveness of therapy. An attentive study of the issue of the state of intelligence of patients with comorbid pathology will lead to an improvement in the patient’s social adaptation, a more careful attitude to their somatic health and reduce the risk of disability of the able-bodied population.

2017 ◽  
Vol 3 (2) ◽  
pp. 55-58 ◽  
Author(s):  
NH Rekha ◽  
MS Bharath ◽  
SP Channakeshava

ABSTRACT Introduction Diabetes mellitus is a common metabolic disorder. Prevalence of diabetes is increasing globally and it is one of the major health problems of the 21st century. The disturbance in serum magnesium (SMg) has been reported among patients with type II diabetes mellitus. Hypomagnesemia has negative impact on glucose homeostasis and insulin sensitivity in patients with type II diabetes mellitus. Aim This study was undertaken to know the prevalence of hypomagnesemia in patients with type II diabetes mellitus and its relation with glycated hemoglobin (HbA1c). The study was conducted on 200 patients with type II diabetes and 100 healthy controls at RajaRajeswari Medical College & Hospital, Bengaluru. Results Out of 200 diabetic patients, 115 (57%) had hypomagnesemia. We observed mean SMg (1.7 mg) significantly low in diabetic patients compared with controls (2.1 mg). We also found HbA1c was high (9%) in hypomagnesemia patients. We found that diabetic hypomagnesemic patients had high mean fasting blood glucose (242.6 mg%) and postprandial blood sugar (313 mg%) than controls. How to cite this article Rekha NH, Bharath MS, Channakeshava SP. Study of Prevalence of Hypomagnesemia in Patients with Type II Diabetes Mellitus. J Med Sci 2017;3(2):55-58.


Sign in / Sign up

Export Citation Format

Share Document